149 related articles for article (PubMed ID: 6271510)
21. Evidence for a circulating Na,K-pump inhibitor in essential hypertension.
Hilton PJ
Scand J Clin Lab Invest Suppl; 1986; 180():65-71. PubMed ID: 3012764
[No Abstract] [Full Text] [Related]
22. Sodium transport inhibition, cell calcium, and hypertension. The natriuretic hormone/Na+-Ca2+ exchange/hypertension hypothesis.
Blaustein MP; Hamlyn JM
Am J Med; 1984 Oct; 77(4A):45-59. PubMed ID: 6091450
[TBL] [Abstract][Full Text] [Related]
23. Endogenous digitalislike circulating substances in spontaneously hypertensive rats.
Wauquier I; Pernollet MG; Grichois ML; Lacour B; Meyer P; Devynck MA
Hypertension; 1988 Aug; 12(2):108-16. PubMed ID: 2457551
[TBL] [Abstract][Full Text] [Related]
24. Potassium, Na+-K+ pump inhibitor and low-renin hypertension.
Haddy FJ
Clin Invest Med; 1987 Nov; 10(6):547-54. PubMed ID: 2831002
[TBL] [Abstract][Full Text] [Related]
25. Evidence that the hypothalamus may be a source of a circulating Na+-K+-ATPase inhibitor.
Alaghband-Zadeh J; Fenton S; Hancock K; Millett J; de Wardener HE
J Endocrinol; 1983 Aug; 98(2):221-6. PubMed ID: 6308123
[TBL] [Abstract][Full Text] [Related]
26. Cytochemically assayable Na+,K+-ATPase inhibition by Milan hypertensive rat plasma.
Holland S; Millett J; Alaghband-Zadeh J; de Wardener H; Ferrari P; Bianchi G
Hypertension; 1987 May; 9(5):498-503. PubMed ID: 3032790
[TBL] [Abstract][Full Text] [Related]
27. Sodium metabolism in offspring of hypertensive parents.
Mazzanti L; Rabini RA; Testa I; Coppa GV; Catassi C; Cecconi M; Giorgi PL
Biochem Med Metab Biol; 1991 Apr; 45(2):181-7. PubMed ID: 1652991
[TBL] [Abstract][Full Text] [Related]
28. Renal sodium handling and sodium transport inhibitor in salt-sensitive essential hypertension.
Iwaoka T; Umeda T; Miura F; Inoue J; Sasaki M; Naomi S; Sato T
J Hypertens; 1991 Jan; 9(1):49-54. PubMed ID: 1848259
[TBL] [Abstract][Full Text] [Related]
29. Cellular mechanism relating sodium and potassium to hypertension.
Zhao GS; Li DY; Zhu DL; Kong DW; Qian YW; Li DP
Ann Clin Res; 1984; 16 Suppl 43():55-61. PubMed ID: 6100156
[TBL] [Abstract][Full Text] [Related]
30. Abnormalities of membrane transport in hypertension.
Haddy FJ
Hypertension; 1983; 5(6 Pt 3):V66-72. PubMed ID: 6360883
[TBL] [Abstract][Full Text] [Related]
31. [The role of the Na, K-ATPase inhibitor in renal sodium handling in patients with essential hypertension].
Komura H; Kikuchi K; Nozawa A; Hasegawa T; Suzuki S; Yamamoto M; Satoh N; Ohtomo T; Takada T; Iimura O
Nihon Jinzo Gakkai Shi; 1989 Jul; 31(7):775-81. PubMed ID: 2555614
[TBL] [Abstract][Full Text] [Related]
32. Na-K-ATPase-inhibiting and glucose-6-phosphate dehydrogenase-stimulating activity of plasma and hypothalamus of the Okamoto spontaneously hypertensive rat.
Millett JA; Holland SM; Alaghband-Zadeh J; de Wardener HE
J Endocrinol; 1986 Jan; 108(1):69-73. PubMed ID: 3003223
[TBL] [Abstract][Full Text] [Related]
33. alpha-Adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives.
Glorioso N; Filigheddu F; Cusi D; Troffa C; Conti M; Natalizio M; Argiolas G; Barlassina C; Bianchi G
Hypertension; 2002 Feb; 39(2 Pt 2):357-62. PubMed ID: 11882573
[TBL] [Abstract][Full Text] [Related]
34. Kinetic study of Na+-K+ pump in erythrocytes from essential hypertensive patients.
Diez J; Hannaert P; Garay RP
Am J Physiol; 1987 Jan; 252(1 Pt 2):H1-6. PubMed ID: 3028158
[TBL] [Abstract][Full Text] [Related]
35. Plasma endogenous sodium pump inhibitor in essential hypertension.
Cloix JF; Devynck MA; Elghozi JL; Kamal LA; Lacerda-Jacomini LC; Meyer P; Pernollet MG; Rosenfeld JB; De Thé H
J Hypertens Suppl; 1983 Dec; 1(2):11-4. PubMed ID: 6100615
[TBL] [Abstract][Full Text] [Related]
36. [Effects of saline infusion on the activity of erythrocyte sodium-potassium pump in normal subjects and in patients with essential hypertension].
Forneris G; Boero R; Guarena C; Maffei S; Stramignoni E; Iadarola GM; Borca M; Quarello F
Minerva Urol Nefrol; 1992; 44(1):79-83. PubMed ID: 1326790
[TBL] [Abstract][Full Text] [Related]
37. Inherited defect in a Na+, K-co-transport system in erythrocytes from essential hypertensive patients.
Garay RP; Dagher G; Pernollet MG; Devynck MA; Meyer P
Nature; 1980 Mar; 284(5753):281-3. PubMed ID: 6244501
[TBL] [Abstract][Full Text] [Related]
38. Evidence for a Na-K-ATPase-inhibitor in erythrocytes of patients with essential hypertension.
Walter U; Müller S
Eur J Clin Invest; 1985 Aug; 15(4):209-14. PubMed ID: 2995050
[TBL] [Abstract][Full Text] [Related]
39. Blood pressure in essential hypertension correlates with the concentration of a circulating inhibitor of the sodium pump.
Moreth K; Kuske R; Renner D; Schoner W
Klin Wochenschr; 1986 Mar; 64(5):239-44. PubMed ID: 3009961
[TBL] [Abstract][Full Text] [Related]
40. The role of a humoral Na+,K+-ATPase inhibitor in regulating precapillary vessel tone.
Haddy FJ
J Cardiovasc Pharmacol; 1984; 6 Suppl 2():S439-56. PubMed ID: 6206353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
